Mandy and Ballinger
Mandy and Ballinger
Group Leader, Genetic Cancer Risk, Garvan Institute of Medical Research
Verified email at garvan.org.au
Title
Cited by
Cited by
Year
Li-Fraumeni syndrome: cancer risk assessment and clinical management
KA McBride, ML Ballinger, E Killick, J Kirk, MHN Tattersall, RA Eeles, ...
Nature reviews Clinical oncology 11 (5), 260, 2014
1702014
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
ML Ballinger, DL Goode, I Ray-Coquard, PA James, G Mitchell, ...
The Lancet Oncology 17 (9), 1261-1271, 2016
1302016
Regulation of glycosaminoglycan structure and atherogenesis
ML Ballinger, J Nigro, KV Frontanilla, AM Dart, PJ Little
Cellular and Molecular Life Sciences CMLS 61 (11), 1296-1306, 2004
932004
Baseline surveillance in Li-Fraumeni syndrome using whole-body magnetic resonance imaging: a meta-analysis
ML Ballinger, A Best, PL Mai, PP Khincha, JT Loud, JA Peters, MI Achatz, ...
JAMA oncology 3 (12), 1634-1639, 2017
912017
TGF-β stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2
ML Burch, SNY Yang, ML Ballinger, R Getachew, N Osman, PJ Little
Cellular and Molecular Life Sciences 67 (12), 2077-2090, 2010
892010
Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis
PJ Little, ML Ballinger, N Osman
Vascular Health and Risk Management 3 (1), 117, 2007
852007
A genome-wide scan identifies variants in NFIB associated with metastasis in patients with osteosarcoma
L Mirabello, R Koster, BS Moriarity, LG Spector, PS Meltzer, J Gary, ...
Cancer discovery 5 (9), 920-931, 2015
712015
Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor β type I …
ML Burch, ML Ballinger, SNY Yang, R Getachew, C Itman, K Loveland, ...
Journal of Biological Chemistry 285 (35), 26798-26805, 2010
692010
Glycosaminoglycan synthesis and structure as targets for the prevention of calcific aortic valve disease
KJ Grande-Allen, N Osman, ML Ballinger, H Dadlani, S Marasco, PJ Little
Cardiovascular research 76 (1), 19-28, 2007
672007
Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo
ML Ballinger, N Osman, K Hashimura, JB Haan, K Jandeleit‐Dahm, ...
Journal of cellular and molecular medicine 14 (6b), 1408-1418, 2010
632010
Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle
H Dadlani, ML Ballinger, N Osman, R Getachew, PJ Little
Journal of Biological Chemistry 283 (12), 7844-7852, 2008
632008
PDGF β-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL
R Getachew, ML Ballinger, ML Burch, JJ Reid, LM Khachigian, TN Wight, ...
Endocrinology 151 (9), 4356-4367, 2010
552010
High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort
G Mitchell, ML Ballinger, S Wong, C Hewitt, P James, MA Young, ...
PloS one 8 (7), e69026, 2013
542013
Biosynthesis of natural and hyperelongated chondroitin sulfate glycosaminoglycans: new insights into an elusive process
PJ Little, ML Ballinger, ML Burch, N Osman
The open biochemistry journal 2, 135, 2008
482008
Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL
ML Ballinger, ME Ivey, N Osman, WG Thomas, PJ Little
Atherosclerosis 205 (2), 451-457, 2009
402009
Recommended guidelines for validation, quality control, and reporting of TP53 variants in clinical practice
B Leroy, ML Ballinger, F Baran-Marszak, GL Bond, A Braithwaite, ...
Cancer research 77 (6), 1250-1260, 2017
382017
Diagnosis of fusion genes using targeted RNA sequencing
EE Heyer, IW Deveson, D Wooi, CI Selinger, RJ Lyons, VM Hayes, ...
Nature communications 10 (1), 1-12, 2019
342019
Fenofibrate modifies human vascular smooth muscle proteoglycans and reduces lipoprotein binding
J Nigro, ML Ballinger, RJ Dilley, GLR Jennings, TN Wight, PJ Little
Diabetologia 47 (12), 2105-2113, 2004
332004
Surveillance recommendations for patients with germline TP53 mutations
ML Ballinger, G Mitchell, DM Thomas
Current opinion in oncology 27 (4), 332-337, 2015
322015
Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein …
LEM Cardoso, PJ Little, ML Ballinger, CK Chan, KR Braun, ...
Journal of Biological Chemistry 285 (10), 6987-6995, 2010
322010
The system can't perform the operation now. Try again later.
Articles 1–20